Gestational Trophoblastic Disease clinical trials

The registry lists 57 studies for Gestational Trophoblastic Disease across more than 10 countries. 16 are recruiting or about to start. 32 of them are mainly about Gestational Trophoblastic Disease (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-03.

Get an email when these change. Save the Gestational Trophoblastic Disease studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 25
Recruiting: 14
Status unknown: 7
Terminated: 5
Active, not recruiting: 3
Not yet recruiting: 2

Phase

Phase 2: 27
Phase 3: 9
Phase 1: 7

Where

United States: 30
China: 12
France: 4
United Kingdom: 2
Egypt: 2
Italy: 1

Who runs them

Fred Hutchinson Cancer Center (5) · Women's Hospital School Of Medicine Zhejiang University (5) · Gynecologic Oncology Group (4) · Peking Union Medical College Hospital (4) · Hospices Civils de Lyon (4) · Vanderbilt-Ingram Cancer Center (2) · Assiut University (2) · Ohio State University Comprehensive Cancer Center (2)

What is being tested here

Drugs under test in Gestational Trophoblastic Disease studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Toripalimab	2	0	2
Dactinomycin	1	1	4
Camrelizumab	1	0	2
Pembrolizumab	1	0	2
Paclitaxel	1	1	1
Cisplatin	1	1	1
Methotrexate	0	1	2
Alemtuzumab	0	0	2
Domvanalimab	0	0	1
Zimberelimab	0	0	1

Drug classes tested here Immune checkpoint inhibitors 4 open · Antimetabolites 3 · Corticosteroids 3

Coming up

2phase 3 studies under way

3studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3

Dec 2026Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia · Peking Union Medical College Hospital
Dec 2026Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia · Women's Hospital School Of Medicine Zhejiang University
Jan 2027Uterine Artery Doppler Flow Velocimetry Parameters for Predicting the Occurrence of Persistent Gestational Trophoblastic Neoplasia After Evacuation of Complete Hydatiform Mole · Minia University

Who these studies take

Of the 14 Gestational Trophoblastic Disease studies recruiting now, 6 (43%) set no upper age limit and 8 (57%) stop at 75 or younger. 6 (43%) take children under 18. 14 (100%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 14
Age	Women	Men
10	4 (29%)	0 (0%)
18	14 (100%)	0 (0%)
30	14 (100%)	0 (0%)
40	14 (100%)	0 (0%)
50	14 (100%)	0 (0%)
65	7 (50%)	0 (0%)
75	7 (50%)	0 (0%)
85	6 (43%)	0 (0%)

Across all 57 studies, recruiting or not: 39% stop at 75 or younger and 28% at 65; 30% take children; 61% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 57. Browse all 57 → or search them.